
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Pr
Keywords: سودوموناس آئروژینوزا; Ceftolozane/tazobactam; Drug resistance; Enterobacteriaceae; Pseudomonas aeruginosa; Asia-Pacific; Surveillance;